Related by context. All words. (Click for frequent words.) 75 oral prodrug 74 CD# CEA 73 selective androgen receptor modulator 73 selective GR 71 R#/MEM # 71 drug pipeline TAFA# 71 metaglidasen 71 CYT# potent vascular disrupting 71 orally administered inhibitor 71 XL# anticancer compounds 71 CORLUX CORT # 71 ENMD # 71 ALN PCS 71 CCX# 70 ALN TTR# 70 PDE4 inhibitor 70 Panzem R 70 MEK inhibitor 70 mertansine 70 anti amnesic 70 glucagon receptor 70 ALN VSP 70 ALN TTR 70 XL# XL# XL# XL# 70 Archexin 69 Aganocide R 69 ocular formulation 69 HGS ETR2 69 Solazed TM 69 PS# [001] 69 novel VDA molecule 69 Aganocide ® 69 investigational humanized monoclonal antibody 69 tubulin inhibitor 69 lintuzumab SGN 69 AEG# 69 CCR9 antagonist 69 diarrhea predominant irritable 69 Tyrima 69 investigational monoclonal antibody 69 THR beta agonist 69 MCSP respectively 69 JAK1 68 OXi# 68 PEG SN# 68 IMiDs ® 68 TRAIL receptor antibodies 68 HCV polymerase inhibitors 68 non nucleoside HCV 68 CK # novel 68 JAK inhibitor 68 synthetic retinoid 68 IAP inhibitor 68 huC# DM4 68 HGS ETR1 68 Preclinical studies suggest 68 XmAb# 68 tiapamil 68 TELINTRA 68 Chemophase 68 PNP inhibitor 68 small molecule defensin 68 cannabinor 68 Phase Ib clinical trials 68 Traficet EN 68 preclinically 68 alvespimycin 68 favorable pharmacokinetic profile 68 HGS# 68 TKB# 68 virus HCV protease inhibitor 68 AAG geldanamycin analog 68 liposomal formulation 68 cMET 68 urocortin 2 68 Capesaris 68 sodium glucose cotransporter 68 #ME# 68 MEK inhibitors 67 HGS ETR1 mapatumumab 67 PRTX 67 Nanobody ® 67 Exelixis compounds 67 R#/MEM 67 tezampanel 67 rHuPH# enzyme 67 OMNARIS HFA 67 HuMax EGFr 67 vascular disrupting agents 67 visilizumab 67 HuLuc# 67 Ophena TM 67 sodium Injection 67 Novolimus 67 SIRT1 activators 67 dextromethorphan quinidine 67 IMiDs R 67 RGB # 67 Dapagliflozin 67 HCD# [002] 67 Exherin TM 67 HCV protease inhibitors 67 Sym# 67 highly selective inhibitor 67 Nanobody 67 forodesine 67 LEP ETU 67 MAGE A3 ASCI 67 OMP #M# 67 LY# [003] 67 immunosuppressive compound 67 Symadex 67 Epothilones 67 P#X# antagonist 67 evaluating tivozanib 67 JAK inhibitors 67 oral nucleoside analogue 67 Lixivaptan 67 CD# monoclonal antibody 67 Aurora kinase 67 PORxin TM platforms 67 Bezielle 67 histone deacetylase HDAC inhibitor 67 CINOD 67 Panzem R NCD 67 SARMs 67 prokinetic agent 66 TRIOLEX ™ 66 HCV protease 66 angiotensin analog 66 INCB# [001] 66 RAS MAPK pathway 66 CTAP# Capsules 66 HQK 66 Genasense ® oblimersen 66 epothilone 66 CA4P 66 alagebrium 66 Rigel R# 66 IAP inhibitors 66 antagomirs 66 CBLC# 66 GTC recombinant human 66 NGX# 66 DNA RNA Medicines 66 reversible inhibitor 66 Triolex 66 TRIOLEX HE# APOPTONE HE# 66 Chrysalin 66 Azedra 66 PXD# 66 selective modulator 66 ISIS # 66 Aganocide 66 PRX # 66 Cetrorelix 66 Pharmos proprietary 66 5 HT6 receptor 66 tanespimycin 66 CEQ# 66 elotuzumab 66 antiangiogenic activity 66 targeted radiotherapeutic 66 BiovaxID TM 66 neuroprotective properties 66 APOPTONE 66 FGFR 66 preclinical efficacy 66 MGCD# [001] 66 TRIOLEX 66 Curaxin CBLC# 66 Zoraxel 66 TÎ ² 4 66 Apoptone 66 Pharmos pipeline 66 TriRima 66 Zenvia ™ 66 squalamine 66 systemic RNAi therapeutic 66 Bicifadine 66 Anavex #-# 66 alkylating agent 66 Factor VIIa 66 entinostat 66 IMiDs 66 ALN HPN 66 cortisol receptor 66 HCV protease inhibitor 66 PI3K/mTOR 66 Synavive 66 lesinurad 66 GAP #B# 66 formerly LymphoStat B 66 receptor tyrosine kinase inhibitor 66 SNT MC# 66 Ozarelix 66 orally bioavailable 66 vascular disrupting agent 65 Hsp# inhibitors 65 Pimavanserin 65 rxRNA 65 ARRY # 65 candidate CRLX# 65 immune stimulatory 65 CORLUX 65 Cannabinor 65 Elagolix 65 acetonide FA 65 Janus kinase 65 SAR# [004] 65 AtuRNAi 65 antiangiogenic 65 BRAF kinase 65 peripherally acting 65 mGluR5 NAM 65 potent antiproliferative 65 Optiquel ™ 65 lumiliximab 65 pathophysiological effects 65 TAFA# 65 cleavable linker 65 kidney urologic 65 CR# vcMMAE 65 Interferon alpha 65 5 HT2A inverse 65 Squalamine 65 PEGylated anti 65 pan HDAC inhibitor 65 TPI ASM8 65 PSMA ADC 65 telomerase therapeutic 65 protein tyrosine phosphatase 1B 65 lomitapide 65 INS# [001] 65 SNALP technology 65 PRT# 65 hyperphenylalaninemia HPA due 65 CD4 monoclonal antibody 65 romazarit 65 dihydrochloride Tablets 65 #D#C# 65 refractory gout 65 Selective Electrochemical Tumor Ablation 65 PSN# [002] 65 candidate XP# 65 mGluR2 NAM 65 FOLFOX6 chemotherapy regimen 65 Oracea TM 65 GSK# [002] 65 dyskinesia PD LID 65 NS#/#A protease 65 SAR# [002] 65 Aplidin R 65 anticancer compound 65 trastuzumab Herceptin R 65 OncoVEX GM CSF 65 SinuNase TM 65 ganetespib 65 AeroLEF TM 65 CYP#A# CYP#D# 65 PLK1 SNALP 65 GALNS 65 TNF Tumor Necrosis Factor 65 ARIKACE ™ 65 ostarine 65 nucleoside analogs 65 MGd 65 Valortim ® 65 XP# XP# 65 JAK2 inhibitor 65 mapatumumab 65 rHuPH# recombinant human 65 immunomodulating 65 Xanafide 65 Fleximer 65 TLK# 65 Personalized Immunotherapy 65 erlotinib Tarceva ® 65 novel histone deacetylase 65 Aflibercept 65 VEGF inhibitors 65 pomalidomide 65 hypoxia selective 65 Panzem 65 exon skipping 65 cancer immunotherapies 65 immunomodulatory 65 Preclinical studies 65 Ostarine 65 AzaSite Plus 65 NTDDS 65 VA# [002] 65 Factor Receptor 65 opioid induced bowel dysfunction 65 familial amyloidotic polyneuropathy FAP 65 selective inhibitors 65 2 methoxyestradiol 65 Spiegelmer ® 65 LNP formulations 65 polymerase inhibitor 65 iSONEP 65 oral picoplatin 65 mGluR5 negative 65 D aspartate NMDA receptor 65 agonistic human 65 selective kinase inhibitor 65 fosbretabulin 65 Bendavia 65 phase IIb clinical 65 selective androgen receptor modulators 65 certain protein tyrosine 65 Golimumab 65 protein kinase inhibitor 64 Entereg R 64 anti CD3 64 CIMZIA TM 64 IMA# 64 LHRH antagonists 64 highly selective endothelin 64 INT# [002] 64 docetaxel Taxotere R 64 gastrointestinal disorders ATI 64 Xcytrin R 64 riociguat 64 Locked Nucleic Acid LNA 64 Phase 2a clinical trials 64 product platforms AZX# 64 CD# antibody [001] 64 TRO# 64 LymphoStat B TM 64 histone deacetylase inhibitor 64 Phase #b/#a trial 64 Dasatinib 64 kallikrein 64 HIV integrase inhibitors 64 proteasome inhibitor 64 interleukin IL -# 64 sulfonylhydrazine class 64 vascular disrupting 64 nonclinical studies 64 Debio 64 Guanilib 64 NXL# 64 antisense inhibitors 64 TBC# 64 nucleoside analogues 64 sulodexide 64 diabetic neuropathic pain 64 selective adenosine 64 potent anti angiogenic 64 Tezampanel 64 PGL# 64 SERMs 64 dacetuzumab SGN 64 FOLOTYN ® 64 A3 adenosine receptor 64 Posiphen 64 ATL/TV# 64 nucleoside tide 64 Recombinant Human 64 Vidofludimus 64 retaspimycin 64 TG# [003] 64 selective inhibition 64 Naproxcinod 64 ONCONASE R 64 Sphingomab 64 AzaSite Xtra 64 #beta HSD1 64 TKM ApoB 64 Aurora Kinase 64 YONDELIS 64 Prodarsan ® 64 antitumor effects 64 Phase 2a trial 64 polyneuropathy HIV DSP 64 Tß4 64 aripiprazole Abilify 64 oral proteasome inhibitor 64 CCR2 64 proteasome inhibitors 64 Onconase 64 defensin mimetic antibiotic 64 B lymphocyte stimulator 64 RLY# 64 HMG CoA reductase inhibitors 64 TRX1 64 next generation URAT1 64 IMC #B 64 mocetinostat MGCD# 64 uricase 64 AKT inhibitor 64 PrevOnco ™ 64 Solazed ™ 64 Phase IIa trials 64 Protexia ® 64 PEGPH# 64 Darinaparsin 64 sorafenib tablets 64 JAK#/JAK# 64 generation Hsp# inhibitor 64 DXL# 64 peptidic compound 64 vaccine GRNVAC1 64 Zemiva TM 64 MKC# MT 64 Phenoptin 64 RDEA# 64 small molecule thrombopoietin 64 rilonacept 64 Perifosine 64 systemically administered 64 anti EGFR antibody 64 zileuton 64 PHX# 64 demonstrated antitumor activity 64 aldehyde dehydrogenase ALDH2 deficiency 64 inhibitor PPI 64 Amplimexon 64 dasatinib Sprycel ® 64 factor receptor FGFR 64 androgen receptor modulator 64 GFT# 64 humanized monoclonal antibodies 64 HspE7 64 vivo validation 64 ularitide 64 TRANSDUR ™ 64 CIMZIA ™ 64 investigational protease inhibitor 64 Linjeta TM 64 CRx 64 teduglutide 64 sodium thiosulfate STS 64 taxane resistant 64 catheter occlusion 64 delta opioid receptor 64 histone deacetylase HDAC 64 XL# inhibits 64 SRT# [003] 64 gastro intestinal inflammation 64 RECOTHROM R 64 BiTE antibodies targeting 64 arsenic trioxide injection 64 S1P antibody 64 Ep CAM 64 GRN# 64 Serdaxin ® 64 phase IIb study 64 COX Inhibiting Nitric Oxide 64 Stedivaze 64 HCV NS5B polymerase 64 NR2B selective 64 Tumor Necrosis Factor 64 acyclovir Lauriad R 64 Lenocta 64 octreotide implant 64 HSP# inhibitor 64 Oral NKTR 64 mu opioid receptor antagonist 64 Azedra ™ 64 receptor inhibitor 64 NeuroSTAT ® 64 phosphate S1P 64 AQ4N 64 Nanobodies 64 GMX# 64 PDE4 64 ASONEP 64 IMC A# 64 potent inhibition 64 safinamide 64 INxin TM 64 Phase 1a clinical 64 DAVANAT 64 CB2 selective receptor agonist 64 HCV nucleoside polymerase inhibitors 64 Completes Patient Enrollment 64 novel immunomodulatory 64 ApoB SNALP 64 orally dosed 64 preclinical compounds 64 plasma kallikrein inhibitor 64 IL #E 63 aurora kinase 63 selective antagonist 63 JAK3 63 ALV# 63 clinical trials dacetuzumab SGN 63 trastuzumab DM1 T DM1 63 P#X# 63 oral gallium 63 NB S# strontium malonate 63 motexafin gadolinium Injection 63 pharmacological chaperone 63 delafloxacin 63 radezolid 63 TNF alpha antagonist 63 delta isoform 63 nicotinic alpha 7 63 pradefovir 63 RNA antagonist 63 SinuNase ™ 63 Resten NG 63 PDE# 63 TACI Ig 63 docetaxel Taxotere ® 63 VIAtab TM 63 Androxal TM 63 nucleotide analog 63 tafamidis 63 ELADUR 63 triterpenoids 63 OMP #R# 63 favorable pharmacokinetic 63 IRX 2 63 DDP# 63 BCG refractory carcinoma 63 TOCOSOL Camptothecin 63 siRNA therapeutic 63 PORxin TM 63 Epratuzumab 63 ATL# [002] 63 Marqibo TM 63 CCR5 antagonist 63 MGCD# MGCD# [001] 63 Myocet 63 Phase 2b Clinical Trial 63 Pivotal Phase 63 AVE# 63 Cyclooxygenase Inhibiting Nitric Oxide 63 thymalfasin 63 phase IIa clinical 63 Nanobodies ® 63 multi kinase inhibitor 63 resolvin 63 budesonide foam 63 trastuzumab Herceptin 63 Vilazodone 63 BCX# 63 RNAi therapeutic targeting PCSK9 63 candidates Augment ™ 63 ceftazidime 63 lenalidomide Revlimid R 63 Pathway Inhibitor 63 DR Cysteamine 63 insulin sensitizers 63 GLP toxicology studies 63 nalbuphine ER 63 TELCYTA 63 Locked Nucleic Acid 63 evaluating mipomersen 63 NOX E# 63 XL# XL# 63 EOquin 63 Survivin antagonist 63 Annamycin 63 MTP inhibitor 63 Pivotal Phase III 63 EZN 63 oral isoform selective HDAC 63 Meets Primary Endpoint 63 obatoclax 63 CTA# Injection 63 lexidronam injection 63 Hsp# inhibitor 63 novel anticancer 63 dasatinib Sprycel 63 XOMA 3AB 63 partial agonist 63 CCR5 mAb 63 TRANSDUR ® 63 Romidepsin 63 OHR/AVR# 63 immune modulatory 63 selective A2A adenosine receptor 63 GAMMAGARD 63 Omacetaxine 63 p# MAP kinase inhibitor 63 PEGylated interferon 63 IMPDH inhibitor 63 ospemifene 63 Triapine R 63 Quinamed 63 tezampanel NGX# 63 Tumour Vascular Disrupting Agent 63 Imetelstat 63 Tesetaxel 63 glucokinase activator 63 Indibulin 63 2 inhibitor CYT# 63 polymerase inhibitors 63 MEK ERK 63 celgosivir 63 LEVAQUIN ® 63 inflammatory autoimmune diseases 63 Smac mimetics 63 therapeutic monoclonal antibody 63 teriflunomide 63 ADP receptor antagonist 63 PDX pralatrexate 63 class mGluR5 inhibitor 63 DEB# 63 HIF PH inhibitors 63 Epothilone D 63 clinical trials SGN 63 Phase 1b clinical trials 63 small molecule Hedgehog 63 adipiplon 63 novel L DOS# 63 antiangiogenesis therapies 63 Zorbtive TM 63 DexaSite 63 incyclinide 63 ATRA IV 63 Allovectin 7 R 63 ANAVEX #-# [001] 63 pharmacodynamic effects 63 anticancer activity 63 subsidiaries visit http:/www.apricusbio.com 63 S#P# 63 mTOR inhibitors 63 PEGylated Fab fragment 63 aplindore 63 ATL# [001] 63 Azixa 63 torezolid phosphate 63 Varespladib 63 ELADUR ™ 63 AZX# 63 AQD class 63 delivery polymer matrix 63 anti fibrotic 63 alefacept 63 anionic backbone 63 MEK inhibitor RDEA# 63 Palifosfamide 63 sulindac 63 Monoclonal Antibody 63 AEGR 63 5 HT3 receptor 63 panitumumab Vectibix 63 Radezolid 63 octreotide acetate 63 orally bioavailable mimics 63 antitumor 63 PI3K/Akt pathway inhibitor 63 teplizumab 63 CXB# 63 Phase Ib study 63 LibiGel ® 63 mRNA antagonists 63 prostone 63 Iloperidone 63 potent antitumor activity 63 agonists antagonists 63 Curaxin 63 PTP 1B 63 include PLX IBD 63 pseudobulbar affect PBA 63 Phase #/#a trial 63 Tarvacin TM 63 Hsp# inhibition 63 ANAVEX #-# [002] 63 IL# PE#QQR 63 VitiGam 63 SPRYCEL ® 63 Hsp# Inhibitor 63 ISTODAX 63 Myolimus 63 refractory chronic lymphocytic 63 custirsen 63 lucinactant 63 Prestara 63 generation nucleoside analog 63 Fulvestrant 63 dacetuzumab 63 pertuzumab 63 Imprime PGG 63 ESBA# 63 Y2 receptor 63 SomatoKine 63 Aurora kinase inhibitor 63 BNC# 63 prostanoid 63 Blinatumomab 63 myelofibrosis polycythemia vera 63 radiolabeled monoclonal antibody 63 midstage trials 63 stable nucleic acid 63 ruxolitinib 63 omega interferon 63 novel topoisomerase 63 Vascugel 63 cystinosis patients 63 HCV nucleotide polymerase inhibitor 63 mecamylamine 63 Aurexis 63 cilengitide 63 novel peptide 63 NMDA antagonist 63 LPA1 receptor 63 rNAPc2 63 Fx #A 63 Carfilzomib 63 reversible inhibitors 63 FLT3 63 cyclophilin inhibitor 63 telomerase inhibitor drug 63 Onalta ™ 63 hormone LHRH antagonist 62 Initiates Enrollment 62 5 HT6 62 oncolytic virus therapies 62 solid tumors ZYBRESTAT 62 PEG irinotecan 62 Elotuzumab 62 Crofelemer budesonide foam 62 TLR9 agonist 62 Mg Usa 62 interferon IFN 62 Phase IIa clinical trials 62 Parkinson disease levodopa induced 62 BioVant 62 luteinizing hormone releasing 62 generation URAT1 inhibitor 62 INCB# [003] 62 Clusterin 62 LY# [002] 62 trastuzumab Herceptin ® 62 HuCAL PLATINUM ® CysDisplay 62 bevacizumab Avastin ® 62 TRPV1 agonist 62 PEG PAL 62 allosteric modulator NAM 62 CCR2 receptor 62 PREOS R 62 Vicinium TM 62 valopicitabine 62 5 HT2A receptor 62 Maribavir 62 NEUGENE 62 sPLA2 62 allosteric modulator 62 inhibitor RG# 62 TLR antagonists 62 JAK Inhibitor 62 targeting CD# 62 TLR9 agonists 62 novel synthetic PEGylated 62 davalintide 62 multitargeted 62 pharmacodynamic markers 62 opioid bowel dysfunction 62 BAY #-# 62 KNS # 62 pentadentate logo R 62 antibody MAb 62 Locteron ® 62 HDAC inhibition 62 Akt inhibitor 62 ThermoDox ® clinical 62 GED aPC 62 Silodosin 62 PEGylated 62 drug ISA# 62 5 HT2A serotonin 62 Homspera TM 62 CD3 monoclonal antibody 62 Aliskiren 62 oral salmon calcitonin 62 molecularly targeted 62 pegylated interferons 62 Hematide ™ 62 MAXY G# 62 Proellex TM 62 tramiprosate Alzhemed TM 62 Fortical R 62 MYDICAR ® 62 SYN# 62 R Saizen R 62 humanized anti 62 AeroLEF R 62 CaPre TM 62 Tarceva TM 62 HDL Mimetic Peptide 62 Insegia 62 MET amplification 62 novel synthetic peptide 62 HuMax 62 Protein Kinase C 62 oral rivaroxaban 62 FUSILEV enhances 62 MT#/MEDI-# 62 Anticalin R 62 mda 7 62 rFIXFc 62 IMiDs ® compound 62 KSP inhibitor 62 Nektar proprietary 62 Intravenous Human 62 KB# [002] 62 renin inhibitors 62 DNA methyltransferase inhibitors 62 prescribed proton pump 62 selective agonist 62 DFMO 62 Safinamide 62 BCR ABL inhibitors 62 vapreotide acetate 62 torsemide ER 62 IgG1 antibody 62 tyrosine kinase inhibitor 62 Fludara ® 62 LymphoStat B belimumab 62 IMP# 62 Phase 2a Clinical Trial 62 Curaxins 62 Pancreate 62 alpha 2A 62 GVAX ® 62 FBPase 62 PCK# 62 ponatinib 62 Granulocyte Colony Stimulating Factor 62 trastuzumab emtansine T DM1 62 bexarotene 62 Irinotecan 62 MAP# 62 NMDA antagonists 62 SB# ONX 62 Sudhir Agrawal D.Phil 62 albiglutide 62 ACAPODENE 62 Pafuramidine 62 preclinical studies 62 bazedoxifene conjugated estrogens 62 regorafenib 62 Solorel TM 62 atacicept 62 anticancer agents 62 CORT # estimates 62 mGluR2 positive 62 potent inhibitors 62 Augment TM 62 Virulizin ® 62 EGS# 62 interferon gamma 1b 62 TOCOSOL Paclitaxel 62 please visit www.advaxis.com 62 Methylnaltrexone 62 poly ADP ribose polymerase 62 Initiate Phase 62 ZYBRESTAT fosbretabulin 62 LE SN# 62 ACV1 62 oral FTY# 62 ProSavin 62 ZFP Therapeutics 62 Tesmilifene 62 Aplidin 62 nitric oxide donating 62 Kosan dependence 62 Randomized Phase 62 dexamethasone Decadron 62 VDAs 62 2A receptor agonist 62 ICA # 62 peroxisome proliferator activated 62 RhuDex ® 62 pralatrexate injection folate analogue 62 RAV# 62 synthetic cannabinoid library 62 small molecule glucokinase 62 targeting PCSK9 62 vorinostat 62 EndoTAG TM -1 62 proprietary PEGylation 62 RON Notch 62 beta Estradiol 62 TLR8 62 Kahalalide F 62 IND submission 62 TTR gene 62 adrenergic regulation 62 R roscovitine 62 flavopiridol 62 PROMACTA 62 Interferon beta 1a 62 Serostim ® 62 KL4 Surfactant 62 TLR7 62 investigational pan BCR 62 neurokinin 1 62 Telik logo TELINTRA 62 Ceflatonin 62 Trofex 62 OMNARIS Nasal Spray 62 Neulasta R 62 Relivar 62 antisense inhibition 62 liposomal 62 antiapoptotic 62 Afatinib 62 methylnaltrexone bromide 62 DermaVir 62 Anticalin 62 K ras mutations 62 bicifadine 62 CG# [003] 62 oral JAK1 62 TREANDA 62 bortezomib Velcade 62 GPR# agonist 62 Bafetinib 62 phase IIb trial 62 Glufosfamide 62 antibody MT# 62 c Raf kinase 62 renal toxicity 62 non nucleoside inhibitor 62 ulimorelin 62 Miraxion Amarin lead 62 vilazodone 62 novel nucleoside analog 62 ON #.Na 62 agonist compounds 62 transthyretin mediated amyloidosis ATTR 62 ZOLINZA 62 Thiarabine 62 HepeX B 62 humanized antibodies 62 sodium glucose transporter 62 epothilones 62 BXT # 62 NS5B polymerase 62 Delta opioid receptor 62 omecamtiv mecarbil formerly 62 anti angiogenic agent 62 modulator SERM 62 candidate Zenvia 62 #I TM# 62 esomeprazole Nexium 62 nucleoside analog 62 alpha folate receptor 62 developing ostarine selective 62 Phase #b/#a clinical 62 endothelin receptor 62 Arikace 62 HuMax CD# 62 telaprevir VX 62 KRN# 62 Vidaza ® 62 SCH # 62 elagolix 62 darapladib 62 Menerba 62 developing Bicifadine serotonin 62 Poly ICLC 62 TO AVOID PREGNANCY WHILE 62 clinical trials Archexin ® 62 CINQUIL 62 Budesonide foam crofelemer 62 CGEN # 62 5 FU leucovorin 62 EDEMA3 trial 62 Xyfid TM 62 recombinant biopharmaceutical 62 corticosteroid dexamethasone 62 GSK3B 62 Adenoscan R 62 vaccines oncolytic virus 62 liposomal doxorubicin 62 Zolinza 62 plus Copegus R 62 GATTEX ® 62 perampanel 62 Pertuzumab 62 selective antagonists 62 5alpha reductase 62 angiogenesis inhibitor 62 CD# expressing 62 Regeneron Pharma 62 compound INCB# 62 vinca alkaloids 62 Mipomersen 62 IMiD 62 SILENOR 62 HuCAL GOLD R 62 Bioral 62 apricitabine ATC 62 TNFalpha 62 Tasimelteon 62 GLYX 62 S/GSK# 62 antisense drug 62 polysaccharide polymer 62 TransVax ™ 62 non selective NMDA